{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:01:11Z","timestamp":1777561271318,"version":"3.51.4"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Insulin-induced type III hypersensitivity reactions (HSRs) are exceedingly rare and pose complex diagnostic and management challenges. We describe a case of a 43-year-old woman with type 1 diabetes mellitus (DM), severe insulin resistance, and subcutaneous nodules at injection sites, accompanied by elevated anti-insulin IgG autoantibodies. Treatment involved therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) as bridge therapy, followed by long-term immunosuppression, which reduced autoantibody levels and improved insulin tolerance. Given the limited treatment guidelines, we conducted a comprehensive literature review, identifying 16 similar cases. Most patients were females with a median age of 36.5 years; 63% had type 1 DM, and 44% had concurrent insulin resistance (56% with elevated autoantibodies). Treatment approaches varied, with glucocorticoids used in 67% of cases. Patients with type 1 DM were less responsive to steroids than those with type 2 DM, and had a more severe course. Of those patients with severe disease necessitating immunosuppression, 66% had poor responses or experienced relapses. The underlying mechanism of insulin-induced type III HSRs remains poorly understood. Immunosuppressive therapy reduces anti-insulin IgG autoantibodies, leading to short-term clinical improvement and improved insulin resistance, emphasizing their crucial role in the condition. However, the long-term efficacy of immunosuppression remains uncertain and necessitates continuous evaluation and further research.<\/jats:p>","DOI":"10.3389\/falgy.2024.1357901","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T05:36:32Z","timestamp":1708493792000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A\u00a0case report and systematic literature review: insulin-induced type III hypersensitivity reaction"],"prefix":"10.3389","volume":"5","author":[{"given":"Rebecca R.","family":"Meredith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polly","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinelo Pamela","family":"Onyenekwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herleen","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Tversky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Alvarez-Arango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"844040","DOI":"10.3389\/fendo.2022.844040","article-title":"Insulin allergy to detemir followed by rapid onset of diabetic ketoacidosis: a case report and literature review","volume":"13","author":"Teo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clindermatol.2010.11.009","article-title":"Insulin allergy","volume":"29","author":"Ghazavi","year":"2011","journal-title":"Clin Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1398-9995.2007.01567.x","article-title":"Insulin allergy: clinical manifestations and management strategies","volume":"63","author":"Heinzerling","year":"2008","journal-title":"Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/dia.2020.0438","article-title":"Recurrent diabetic ketoacidosis and extreme insulin resistance due to anti-insulin antibodies: response to immunosuppression and plasma exchange","volume":"23","author":"Ahmed","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1226231","DOI":"10.3389\/fendo.2023.1226231","article-title":"Case report: insulin hypersensitivity in youth with type 1 diabetes","volume":"14","author":"Alkhatib","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1464-5491.2009.02733.x","article-title":"Serum sickness-like reactions associated with type III insulin allergy responding to plasmapheresis","volume":"26","author":"Bayraktar","year":"2009","journal-title":"Diabet Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1464-5491.2008.02621.x","article-title":"Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy","volume":"26","author":"Greenfield","year":"2009","journal-title":"Diabet Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/pdi.2265","article-title":"Insulin hypersensitivity in type 1 diabetes: investigation and treatment with immunodepletion","volume":"37","author":"Harvey","year":"2020","journal-title":"Pract Diab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1002\/ccr3.3200","article-title":"Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus","volume":"8","author":"Clarke","year":"2020","journal-title":"Clin Case Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.2337\/diacare.28.12.2980","article-title":"Type III allergy to insulin detemir","volume":"28","author":"Darmon","year":"2005","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jcjd.2022.08.006","article-title":"Insulin reactions: what do you do when your treatment\u2019s the trigger?","volume":"47","author":"Edwards","year":"2023","journal-title":"Can J Diabetes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0002-9343(59)90334-1","article-title":"Idiopathic insulin-resistant diabetes mellitus; report of a case associated with insulin allergy","volume":"26","author":"Friedlander","year":"1959","journal-title":"Am J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2337\/diacare.25.1.242","article-title":"Leukocytoclastic vasculitis induced by subcutaneous injection of human insulin in a patient with type 1 diabetes and essential thrombocytemia","volume":"25","author":"Mandrup-Poulsen","year":"2002","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/DAD.0000000000002356","article-title":"Injection site reaction to Various insulins as type III allergy with urticarial vasculitis in a patient with type I diabetes Mellitus","volume":"45","author":"M\u00fcller","year":"2023","journal-title":"Am J Dermatopathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11606-017-4037-7","article-title":"Type III hypersensitivity reaction to subcutaneous insulin preparations in a type 1 diabetic","volume":"32","author":"Murray","year":"2017","journal-title":"J Gen Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.diabres.2010.05.019","article-title":"Type III hypersensitivity to insulin leading to leukocytoclastic vasculitis","volume":"89","author":"Rachid","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"B17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0168-8227(97)00031-4","article-title":"Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient","volume":"36","author":"Silva","year":"1997","journal-title":"Diabetes Res Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1111\/jdi.13838","article-title":"Serious diabetic ketoacidosis induced by insulin allergy and anti-insulin antibody in an individual with type\u20092 diabetes mellitus","volume":"13","author":"Takahashi","year":"2022","journal-title":"J Diabetes Investig"},{"key":"B19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/pgmj.62.731.865","article-title":"Persistent local insulin allergy in a diabetic with chronic lymphatic leukaemia","volume":"62","author":"Winocour","year":"1986","journal-title":"Postgrad Med J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/2229-5178.156386","article-title":"Role of direct immunofluorescence in dermatological disorders","volume":"6","author":"Mysorekar","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/00365519009089170","article-title":"Prevalence of anti-insulin antibodies and its relation to severe hypoglycaemia in insulin-treated diabetic patients","volume":"50","author":"Wredling","year":"1990","journal-title":"Scand J Clin Lab Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/diacare.12.9.641","article-title":"Clinical significance of insulin antibodies in insulin-treated diabetic patients","volume":"12","author":"Van Haeften","year":"1989","journal-title":"Diabetes Care"},{"key":"B23","volume-title":"Type III Hypersensitivity Reaction.","author":"Usman","year":"2023"},{"key":"B24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00000441-200505000-00007","article-title":"Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone","volume":"329","author":"Koyama","year":"2005","journal-title":"Am J Med Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1172\/JCI103262","article-title":"Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects","volume":"35","author":"Berson","year":"1956","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1246-7820(03)00035-1","article-title":"Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases","volume":"10","author":"Bayry","year":"2003","journal-title":"Transfus Clin Biol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1357901\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T10:44:05Z","timestamp":1708944245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1357901\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":26,"alternative-id":["10.3389\/falgy.2024.1357901"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2024.1357901","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"article-number":"1357901"}}